Food Allergy and Anaphylaxis
CEimpact Podcast
English - March 18, 2024 09:00 - 35 minutes - 24.5 MBCourses Education Science ceimpact podcast precept2practice level up gamechangers pharmacy cme cpe pharmacology ceimpact geoff wall Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
The GameChanger
A new study looks at the utility of omalizumab in preventing food allergy reactions after accidental exposure.
ACEis and Beta-blockers should be avoided in patients with recurrent anaphylaxis if possible.
Host
Geoff Wall, PharmD, BCPS, FCCP, BCGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health
Reference
Study: https://www.nejm.org/doi/full/10.1056/NEJMoa2312382
Anaphylaxis guideline: https://www.annallergy.org/article/S1081-1206(23)01304-2/fulltext
Pharmacist Members, REDEEM YOUR CPE HERE!
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)
CPE Information
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss the OUtMATCH study results and their relevance to patients with food allergies.
2. Interpret the new AAAAI anaphylaxis guidelines in relation to patient care.
0.05 CEU/0.5 Hr
UAN: 0107-0000-24-079-H01-P
Initial release date: 03/18/2024
Expiration date: 03/18/2025
Additional CPE details can be found here.